BOLT
Price
$6.19
Change
-$0.03 (-0.48%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
11.92M
26 days until earnings call
ICCC
Price
$6.52
Change
-$0.23 (-3.41%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
61M
28 days until earnings call
Interact to see
Advertisement

BOLT vs ICCC

Header iconBOLT vs ICCC Comparison
Open Charts BOLT vs ICCCBanner chart's image
Bolt Biotherapeutics
Price$6.19
Change-$0.03 (-0.48%)
Volume$1K
Capitalization11.92M
ImmuCell
Price$6.52
Change-$0.23 (-3.41%)
Volume$146
Capitalization61M
BOLT vs ICCC Comparison Chart in %
Loading...
BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ICCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BOLT vs. ICCC commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOLT is a Buy and ICCC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (BOLT: $6.32 vs. ICCC: $6.75)
Brand notoriety: BOLT and ICCC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BOLT: 80% vs. ICCC: 87%
Market capitalization -- BOLT: $11.92M vs. ICCC: $61M
BOLT [@Biotechnology] is valued at $11.92M. ICCC’s [@Biotechnology] market capitalization is $61M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOLT’s FA Score shows that 1 FA rating(s) are green whileICCC’s FA Score has 0 green FA rating(s).

  • BOLT’s FA Score: 1 green, 4 red.
  • ICCC’s FA Score: 0 green, 5 red.
According to our system of comparison, both BOLT and ICCC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOLT’s TA Score shows that 3 TA indicator(s) are bullish while ICCC’s TA Score has 2 bullish TA indicator(s).

  • BOLT’s TA Score: 3 bullish, 3 bearish.
  • ICCC’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, BOLT is a better buy in the short-term than ICCC.

Price Growth

BOLT (@Biotechnology) experienced а +6.76% price change this week, while ICCC (@Biotechnology) price change was +5.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

BOLT is expected to report earnings on Aug 06, 2025.

ICCC is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ICCC($61M) has a higher market cap than BOLT($11.9M). ICCC YTD gains are higher at: 31.068 vs. BOLT (-40.946). ICCC has higher annual earnings (EBITDA): 2.94M vs. BOLT (-61.54M). BOLT has more cash in the bank: 38.8M vs. ICCC (4.6M). ICCC has less debt than BOLT: ICCC (14.7M) vs BOLT (24.7M). ICCC has higher revenues than BOLT: ICCC (27.3M) vs BOLT (3.64M).
BOLTICCCBOLT / ICCC
Capitalization11.9M61M20%
EBITDA-61.54M2.94M-2,092%
Gain YTD-40.94631.068-132%
P/E RatioN/AN/A-
Revenue3.64M27.3M13%
Total Cash38.8M4.6M844%
Total Debt24.7M14.7M168%
FUNDAMENTALS RATINGS
ICCC: Fundamental Ratings
ICCC
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
74
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BOLTICCC
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 9 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ICCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SEOJF8.56N/A
N/A
Stora Enso Oyj
MAORF2.20N/A
N/A
Mandarin Oriental International Ltd.
STBK10.00N/A
N/A
Studio Financial Holdings, Inc.
SLVMF0.11N/A
N/A
Silver Mines Ltd., Sydney
TBXXF0.15-0.01
-6.72%
King Copper Discovery Corp

ICCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICCC has been loosely correlated with NKTX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ICCC jumps, then NKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICCC
1D Price
Change %
ICCC100%
+1.81%
NKTX - ICCC
43%
Loosely correlated
+1.69%
BOLT - ICCC
26%
Poorly correlated
+2.98%
JANX - ICCC
24%
Poorly correlated
+4.25%
TRAW - ICCC
24%
Poorly correlated
N/A
NERV - ICCC
24%
Poorly correlated
+5.04%
More